THE FUTURE FIBROMYALGIA DRUGS? PHARMACEUTICAL SOURCE PREDICTS FOUR DRUG APPROVALS IN COMING YEARS


THE FUTURE FIBROMYALGIA DRUGS?
PHARMACEUTICAL SOURCE PREDICTS FOUR DRUG APPROVALS IN COMING YEARS

resized

Both Sleep and Pain Improved
“Our new analyses of the BESTFIT data show that those patients who reported the greatest improvement in sleep quality were the most likely to experience pain relief,” Seth Lederman, MD, Tonix CEO​
Tonix – the developer of the drug – is moving fast. They reported that their Phase II clinical trial for Tonmya was filled in June of this year and reported results on the trial last month.They’ve already begun final (Phase III) trials.
A former study using EEG indicated the drug was increasing restorative sleep, which in turn was associated with reductions in pain, fatigue and depression. In a good sign for those in really severe pain, the most recent studies tied together pain levels and sleep quality; those FM patients in the most pain received the most improvements in sleep quality.
Dr. Lederman, Tonix CEO, emphasized that the drug is not a sleeping pill; it doesn’t just knock you out – it improves sleep quality.

To Read More, please click this link:
http://www.chronicintractablepainandyou.net/apps/forums/topics/show/13295568-the-future-fibromyalgia-drugs-

Advertisements

Controversy Grows over Journal Article on Pain Treatment


It’s not uncommon for colleagues in the medical profession to disagree. Egos and different medical backgrounds can sometimes lead to heated discussions about the best way to treat patients. But those arguments are usually kept private. That is why it is so unusual for a prominent pain physician to publicly call for another doctor to resign or be fired from her faculty position at a prestigious medical school.
“I believe she should resign her academic post,” says Forest Tennant, MD, referring to Jane Ballantyne, MD, a professor at the University of Washington School of Medicine, who recently co-authored a controversial article in the New England Journal of Medicine (NEJM) that said reducing pain intensity should not be the goal of doctors who treat chronic pain patients. The article also suggests that patients should learn to accept their pain and move on with their lives.
“For somebody in her position as a professor at a university to call for physicians to quit treating pain – or pain intensity – whether acute, chronic, whether rich, poor, disabled or what have you, is totally inappropriate. And it’s an insult to the physicians of the world and an insult to patients. And frankly, she should not be a professor.” Tennant told Pain News Network.
“To suggest that physicians should no longer treat pain intensity and let patients suffer goes beyond any sort of decency or concern for humanity.”

To Read More Please Click This Link:
http://www.chronicintractablepainandyou.net/apps/forums/topics/show/13286284-controversy-grows-over-journal-article-on-pain-treatment?next=

Good Early Monday Morning from Dr. Patty!


Good Early Monday Morning from Dr. Patty! I just wanted to wish you all a low to no pain Monday and hope you come over to our (outside of Facebook) Website. I know you would love it because it was everything you all asked for!

step0005

Poll: Does your current pharmacy have a policy that prohibits the filling of scripts for schedule II narcotics?


2

Polls: Does your current pharmacy have a policy that prohibits the filling of scripts for schedule II narcotics?

To answer please click this link:

Please vote here: http://www.chronicintractablepainandyou.net/chronic-polls-3